AIOM Scientific Publications

AIOM Clinical Practice Guideline for breast neoplasms and colorectal tumors are available in English version.

AIOM position papers, publications and other guidelines
are available in Italian

AIOM articles on Scientific Journals:

• Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.
  Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, Camilli M, Turazza FM, Russo G, Paccone A, Mistrulli R, De Luca L, Di Fusco SA, Tarantini L, Lucà F, Oliva S, Moreo A, Maurea N, Quagliariello V, Ricciardi GR, Lestuzzi C, Fiscella D, Parrini I, Racanelli V, Russo A, Incorvaia L, Calabrò F, Curigliano G, Cinieri S, Gulizia MM, Gabrielli D, Oliva F and Colivicchi F
  Front. Cardiovasc. Med. 10:1223660. (2023) doi: 10.3389/fcvm.2023.1223660 (PDF)
• MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
  Natalicchio A, Montagnani M, Gallo M, Marrano N, Faggiano A, Zatelli MC, Mazzilli R, Argentiero A, Danesi R, D’Oronzo S, Fogli S, Giuffrida D, Gori S, Ragni A, Renzelli V, Russo A, Franchina T, Tuveri E, Sciacca L, Monami M, Cirino G, Di Cianni G, Colao A, Avogaro A, Cinieri S, Silvestris N, Giorgino F.
  ESMO Open. 2023 May 30;8(3):101573. doi: 10.1016/j.esmoop.2023.101573. Epub ahead of print. PMID: 37263082. (PDF)
• Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
  Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, Sacchi P, Baldanti F, Di Maio M, Beretta GD, Cinieri S, Silvestris N
  ESMO Open. 2023 Apr 3;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. (PDF)
• Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
  Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli Er, Porcu L, Torri V, Pinto C; GARIBALDI Study Group
  ESMO Open. 2023 Jan 31;8(1):100777. doi: 10.1016/j.esmoop.2022.100777
• Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
  Faggiano A, Mazzilli R, Natalicchio A, Adinolfi V, Argentiero A, Danesi R, D’Oronzo S, Fogli S, Gallo M, Giuffrida D, Gori S, Montagnani M, Ragni A, Renzelli V, Russo A, Silvestris N, Franchina T, Tuveri E, Cinieri S, Colao A, Giorgino F, Zatelli M C on behalf of the Oncological Endocrinology research group of the Italian Society of Endocrinology
  Critical Reviews in Oncology/Hematology. Volume 180, December 2022, 103826. https://doi.org/10.1016/j.critrevonc.2022.103826 (PDF)
• PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
  Miglietta F, Cinquini M, Dieci M V, Cortesi L, Criscitiello C, Montemurro F, Del Mastro L, Zambelli A, Biganzoli L, Levaggi A, Delle Piane C, Marchiò C, Calabrese M, Fortunato L, Franco P, Meduri B, Fittipaldo V A, Gori S.
  THE BREAST, VOLUME 66, P293-304, DECEMBER 01, 2022, Published ONLINE:October 29, 2022 DOI:https://doi.org/10.1016/j.breast.2022.10.014
• Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).
  Pedrazzoli P, Lasagna A, Cassaniti I, Ferrari A, Bergami F, Silvestris N, Sapuppo E, Di Maio M, Cinieri S, Baldanti F.
  ESMO Open. 2022 Aug;7(4):100548. doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16. PMID: 35853350; PMCID: PMC9434335.
• Nutritional support in surgical oncology: A survey by SICO in collaboration with the Intersociety Italian Working Group for Nutritional Support in Cancer Patients.
  Grieco M, Delrio P, Lorenzon L, Agnes AL, Caccialanza R, Pedrazzoli P, Santoro G, Roviello F, Carlini M; “Intersociety Italian Working Group for Nutritional Support in Cancer Patients (AIOM – SINPE – FAVO – SICO – ASAND)”; AIOM (Italian Association of Medical Oncology); SINPE (Italian Society of Artificial Nutrition and Metabolism); FAVO (Italian Federation of Volunteer-based Cancer Organizations); SICO (Italian Society of Oncological Surgery); ASAND (Technical Scientific Association of Food, Nutrition and Dietetics).
  Surg Oncol. 2022 Aug;43:101788. doi: 10.1016/j.suronc.2022.101788. Epub 2022 Jun 10. PMID: 35749913.
• Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement.
  Beretta GD, Casolino R, Corsi DC, Perrone F, Di Maio M, Cinieri S, Gobber G, Bellani M, Petrini F, Zocchi MT, Traclò F, Zagonel V; Italian Society of Palliative Care (SICP); Italian Society of Psycho-Oncology (SIPO); Italian Society of Anaesthesia, Analgesia, Reanimation, and Intensive Care (SIAARTI); Italian Federation of Voluntary Associations in Oncology (FAVO); Italian Foundation of Medical Oncology (Fondazione AIOM); Italian Association of Medical Oncology (AIOM).
  ESMO Open. 2022 Aug;7(4):100538. doi: 10.1016/j.esmoop.2022.100538. Epub 2022 Jun 23. PMID: 35921761; PMCID: PMC9222406.
• Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
  Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Gori S, Cortesi L, Genuardi M, Turchetti D, De Giorgi U, Di Maio M, Barberis M, Dessena M, Del Re M, Lapini A, Luchini C, Jereczek-Fossa BA, Sapino A, Cinieri S; Italian Scientific Societies.
  ESMO Open. 2022 Jun;7(3):100459. doi: 10.1016/j.esmoop.2022.100459. Epub 2022 May 19. PMID: 35597177; PMCID: PMC9126927.
• SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM).
  Orlacchio A, Guastoni C, Beretta GD, Cosmai L, Galluzzo M, Gori S, Grassedonio E, Incorvaia L, Marcantoni C, Netti GS, Passamonti M, Porta C, Procopio G, Rizzo M, Roma S, Romanini L, Stacul F, Casinelli
  Radiol Med. 2022 May;127(5):534-542. doi: 10.1007/s11547-022-01483-8. Epub 2022 Mar 18. PMID: 35303246; PMCID: PMC9098565.
• Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations
  Riccardo Caccialanza, Paolo Cotogni, Emanuele Cereda, Paolo Bossi, Giuseppe Aprile, Paolo Delrio, Patrizia Gnagnarella, Annalisa Mascheroni, Taira Monge, Ettore Corradi, Michele Grieco, Sergio Riso, Francesco De Lorenzo, Francesca Traclò, Elisabetta Iannelli, Giordano Domenico Beretta, Michela Zanetti, Saverio Cinieri, Vittorina Zagonel, Paolo Pedrazzoli
  Cancer 2022; 13(9): 2705-2716. doi:10.7150/jca.73130 (PDF)
• The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.
  Russo A, Incorvaia L, Capoluongo E, Tagliaferri P, Galvano A, Del Re M, Malapelle U, Chiari R, Conte P, Danesi R, Fassan M, Ferrara R, Genuardi M, Ghiorzo P, Gori S, Guadagni F, Marchetti A, Marchetti P, Midiri M, Normanno N, Passiglia F, Pinto C, Silvestris N, Tallini G, Vatrano S, Vincenzi B, Cinieri S, Beretta G.
  Crit Rev Oncol Hematol. 2022 Jan;169:103567. doi: 10.1016/j.critrevonc.2021.103567. Epub 2021 Dec 8. PMID: 34896250.
• Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
  Natalicchio A., Faggiano A., Zatelli M.C., Argentiero A., D’Oronzo S., Marrano N., Beretta G.D., Acquati S., Adinolfi V., Di Bartolo P., Danesi R., Ferrari P., Gori S., Morviducci L., Russo A., Tuveri E., Montagnani M., Gallo M., Silvestris N., Giorgino F.
  Crit Rev Oncol Hematol. 2022 Jan;169:103572. Epub 2021 Dec 22.PMID: 34954047 (PDF)
• Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study
  Di Cosimo, S.; Tagliaferri, B.; Generali, D.; Giudici, F.; Agustoni, F.; Bernardo, A.; Borgonovo, K.; Farina, G.; Luchena, G.; Luciani, A.; Nolè, F.; Palmeri, L.; Pietrantonio, F.; Poggi, G.; Zucali, P.A.; Balletti, E.; Catania, G.; Bernocchi, O.; D’Antonio, F.; Giordano, M.; Grossi, F.; Lasagna, A.; La Verde, N.; Manzoni, M.; Montagna, B.; Olgiati, A.; Raimondi, A.; Rampinelli, I.; Verri, E.; Zaniboni, A.; Di Maio, M.; Beretta, G.; Danova, M. 
  Cancers 2021, 13(6), 1324; https://doi.org/10.3390/cancers13061324
• Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
  N. Silvestris, A. Argentiero, A. Natalicchio, S. D’Oronzo, G. D. Beretta, S. Acquati, V. Adinolfi, P. Di Bartolo, R. Danesi, A. Faggiano, P. Ferrari, M. Gallo, S. Gori, L. Morviducci, A. Russo, E. Tuveri, M. C. Zatelli, M. Montagnani, F. Giorgino
  ESMO Open. 2021 Jun;6(3):100153. Epub 2021 May 10. PMID: 33984679; PMCID: PMC8134762. (PDF)
• Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
  Gallo M., Adinolfi V., Morviducci L., Acquati S., Tuveri E., Ferrari P., Zatelli M.C., Faggiano A., Argentiero A., Natalicchio A., D’Oronzo S., Danesi R., Gori S., Russo A., Montagnani M., Beretta G.D., Di Bartolo P., Silvestris N., Giorgino F.
  ESMO Open. 2021 Jun;6(3):100155. Epub 2021 May 19. PMID: 34020401; PMCID: PMC8144346. (PDF)
• Patient associations and clinical oncology research: how much does a patient’s voice really matter?
  Franchina V, Cagnazzo C, Di Costanzo A, Arizio F, Frazzetto AME, Gori S, Cenna R, Nicolis F, Procopio G, Adamo V, La Verde N, Nanni O.
  Expert Rev Pharmacoecon Outcomes Res. 2020 Nov 17. doi: 10.1080/14737167.2021.1850274. Epub ahead of print. PMID: 33201731.
• Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
  Nicola Silvestris, Antonella Argentiero, Giordano Domenico Beretta, Paolo Di Bartolo, Monica Montagnani, Romano Danesi, Pietro Ferrari, Stella D’Oronzo, Stefania Gori, Antonio Russo, Silvia Acquati, Marco Gallo
  Critical Reviews in Oncology/Hematology, Volume 154, October 2020, 103066 (PDF)
• Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines.
  Sbrana A, Antonuzzo A, Brunello A, Petrelli F, Pronzato P, Tralongo A, Turrini M, Zoratto F, Danova M.
  Tumori. 2020 Oct;106(5):337-345. doi: 10.1177/0300891620921942. Epub 2020 Jun 2. PMID: 32482149.
• Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM).
  Capelli G, De Simone I, Spolverato G, Cinquini M, Moschetti I, Lonardi S, Masi G, Carlomagno C, Corsi D, Luppi G, Gambacorta MA, Valvo F, Cannizzaro R, Grillo F, Barbaro B, Restivo A, Messina M, Pastorino A, Aschele C, Pucciarelli S.
  J Gastrointest Surg. 2020 Sep;24(9):2150-2159. doi: 10.1007/s11605-020-04635-1. Epub 2020 May 11. PMID: 32394125.
• Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM).
  Tralongo AC, Antonuzzo A, Pronzato P, Sbrana A, Turrini M, Zoratto F, Danova M.
  Tumori. 2020 Aug;106(4):273-280. doi: 10.1177/0300891620927093. Epub 2020 Jun 15. PMID: 32538316.
• Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
  Nicola Silvestris, Oronzo Brunetti, Alessandro Bittoni, Ivana Cataldo, Domenico Corsi, Stefano Crippa, Mirko D’Onofrio, Michele Fiore, Elisa Giommoni, Michele Milella, Raffaele Pezzilli, Enrico Vasile, Michele Reni
  Cancers 2020, 12(6), 1681; https://doi.org/10.3390/cancers12061681 (PDF)
• Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
  Passiglia F, Bertolaccini L, Del Re M, Facchinetti F, Ferrara R, Franchina T, Malapelle U, Menis J, Passaro A, Pilotto S, Ramella S, Rossi G, Trisolini R, Novello S.
  Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25. PMID: 32062311.
• Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.
  Passiglia F, Pilotto S, Facchinetti F, Bertolaccini L, Del Re M, Ferrara R, Franchina T, Malapelle U, Menis J, Passaro A, Ramella S, Rossi G, Trisolini R, Novello S.
  Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28. PMID: 31918343.
• Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM).
  Cirillo M, Carlucci L, Legramandi L, Baldini E, Sacco C, Zagonel V, Leo S, Di Fabio F, Tonini G, Meacci ML, Tartarone A, Farci D, Tortora G, Zaninelli M, Valori VM, Cinieri S, Carrozza F, Barbato E, Fabbroni V, Cretella E, Gamucci T, Lunardi G, Zamboni S, Micallo G, Cascinu S, Pinto C, Gori S.
  J Clin Nurs. 2020 Jan;29(1-2):119-129. doi: 10.1111/jocn.15064. Epub 2019 Oct 21. PMID: 31532035.
• BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.
  Capoluongo E, Verde N, Barberis M, Bella MA, Buttitta F, Carrera P, Colombo N, Cortesi L, Gion M, Guarneri V, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A, Gori S.
  Diagnostics (Basel). 2019 Oct 9;9(4). pii: E146. doi: 10.3390/diagnostics9040146
• Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
  Incorvaia L, Fanale D, Badalamenti G, Barraco N, Bono M, Corsini LR, Galvano A, Gristina V, Listì A, Vieni S, Gori S, Bazan V, Russo A.
  Adv Ther. 2019 Oct;36(10):2600-2617. doi: 10.1007/s12325-019-01057-7. Epub 2019 Aug 20. Review.
• Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives
  Stefania Gori, Massimo Barberis, Maria Angela Bella, Fiamma Buttitta, Ettore Capoluongo, Paola Carrera, Nicoletta Colombo, Laura Cortesi, Maurizio Genuardi, Massimo Gion, Valentina Guarneri, Lorena Incorvaia, Nicla La Verde, Domenica Lorusso, Antonio Marchetti, Paolo Marchetti, Nicola Normanno, Barbara Pasini, Matilde Pensabene, Sandro Pignata, Paolo Radice, Enrico Ricevuto, Anna Sapino, Pierosandro Tagliaferri, Pierfrancesco Tassone, Chiara Trevisiol, Mauro Truini, Liliana Varesco, Antonio Russo, On behalf of the AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group
  Critical Reviews in Oncology/Hematology, Volume 140, August 2019, Pages 67-72, doi: 10.1016/j.critrevonc.2019.05.012
• Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM).
  Dieci MV, Del Mastro L, Cinquini M, Montemurro F, Biganzoli L, Cortesi L, Zambelli A, Criscitiello C, Levaggi A, Conte B, Calabrese M, Fiorentino A, Marchiò C, Tinterri C, Fittipaldo VA, Pappagallo G, Gori S.
  Cancers (Basel). 2019 Aug 8;11(8). pii: E1137. doi: 10.3390/cancers11081137
• Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).
  Facchinetti F, Pilotto S, Metro G, Baldini E, Bertolaccini L, Cappuzzo F, Delmonte A, Gasparini S, Inno A, Marchetti A, Passiglia F, Puma F, Ricardi U, Rossi A, Crinò L, Novello S.
  Tumori. 2019 Jul;105(5_suppl):3-14. doi: 10.1177/0300891619857418
• Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association (AIOM).
  Vitale MG, Bracarda S, Cosmai L, Crocetti E, Di Lorenzo G, Lapini A, Mandressi A, Martorana G, Masini C, Montironi R, Ortega C, Passalacqua R, Porta C, Procopio G, Sepe P, Romano L, Pappagallo GL, Conti G, Guida M, Martignoni G, Nolè F, Pignata S, Gori S, Cartenì G.
  Tumori. 2019 Jul;105(4_suppl):3-12. doi: 10.1177/0300891619853392
• Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?
  Cotogni P, Pedrazzoli P, De Waele E, Aprile G, Farina G, Stragliotto S, De Lorenzo F, Caccialanza R for the AIOM-SINPE-FAVO-Fondazione AIOM Working Group
  J Cancer. 2019 Jul 10;10(18):4318-4325. doi: 10.7150/jca.31611. eCollection 2019
• Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa’ Italiana di Nefrologia (SIN) multidisciplinary consensus position paper
  Silvestris N, Argentiero A, Cosmai L, Porta C, Gesualdo L, Brunori G, Brunetti O, Rampino T, Secondino S, Rizzo G, Pedrazzoli P
  Critical Reviews in Oncology/Hematology, Volume 140, August 2019, Pages 39-51, doi: 10.1016/j.critrevonc.2019.05.016
• An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience.
  Gallo M, Clemente G, Cristiano Corsi D, Michelini M, Suraci C, Farci D, Chantal Ponziani M, Candido R, Russo A, Musacchio N, Pinto C, Mannino D, Gori S.
  Diabetes Res Clin Pract. 2019 May 11. pii: S0168-8227(19)30222-0. doi: 10.1016/j.diabres.2019.04.036.
• Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica.
  Banna GL, Nicolai N, Palmieri G, Ottaviano M, Balzarini L, Barone D, Basso U, Bavila A, Bertoni F, Calliada F, Cai T, Carrafiello G, Condello C, Da Pozzo L, Di Nardo D, Fornarini G, Prayer Galetti T, Garolla A, Giannatempo P, Guerra L, La Spina S, Malatino L, Marchiano’ A, Monti M, Morbiato FF, Morelli F, Nole’ F, Palazzi S, Procopio G, Rosti G, Sacco C, Salvetti A, Salvioni R, Sava T, Secondino S, Serpentini S, Spreafico C, Tavolini IM, Valcamonico F, Verri E, Zucali P, De Giorgi U.
  Crit Rev Oncol Hematol. 2019 May;137:154-164. doi: 10.1016/j.critrevonc.2019.03.006. Epub 2019 Mar 20.
• Consensus document of the Italian Association of Medical Oncology and the Italian Society of Palliative Care on early palliative care.
  Corsi DC, Turriziani A, Cavanna L, Morino P, Ribecco AS, Ciaparrone M, Lanzetta G, Pinto C, Zagonel V.
  Tumori. 2019 Apr;105(2):103-112. doi: 10.1177/0300891618792478. Epub 2018 Aug 29.
• Changes in food habits in cancer patients in Italy: a survey. AIOM – SINPE – FAVO.
  Gavazzi C, Sieri S, Traclò F, Sproviero A, Vandoni G, Ricci R, Stragliotto S, Zagonel V; AIOM-SINPE-FAVO working group.
  Nutrition. 2018 Nov;55-56:140-145. doi: 10.1016/j.nut.2018.04.002. Epub 2018 Apr 20
• Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT).
  Bruno R, Zuccaro V, Pinto C, Puoti M, Gaeta GB, Pagani A, Taliani G, Baldanti F, Cinieri S, Pedrazzoli P.
  Semin Oncol. 2018 Oct;45(5-6):259-263. doi: 10.1053/j.seminoncol.2018.07.004. Epub 2018 Oct 25.
• Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM).
  Dieci MV, Massari F, Giusti R, Inno A, Lombardi G, Noto L, Passaro A, Pietrantonio F, Spada F, Valente M, Di Maio M, Torri V
  ESMO Open 2018;3:e000389. doi: 10.1136/esmoopen-2018-000389
• Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM).
  Gori S, Puglisi F, Cinquini M, Pappagallo G, Frassoldati A, Biganzoli L, Cortesi L, Fiorentino A, Angiolini C, Tinterri C, De Censi A, Levaggi A, Del Mastro L.
  Eur J Cancer. 2018 Aug;99:9-19. doi: 10.1016/j.ejca.2018.04.006. Epub 2018 Jun 7
• To fast, or not to fast before chemotherapy, that is the question.
  Caccialanza R, Cereda E, De Lorenzo F, Farina G, Pedrazzoli P; AIOM-SINPE-FAVO Working Group.
  BMC Cancer. 2018 Mar 27;18(1):337. doi: 10.1186/s12885-018-4245-5.
• Update of the recommendations of the Italian Society of Medical Oncology on vaccination for seasonal influenza and pneumococcal infection in patients with cancer: Focus on prevention of pneumonia.
  Pedrazzoli P, Piralla A, Valentino F, Cinieri S, Baldanti F.
  Eur J Cancer Care (Engl). 2018 Mar;27(2):e12817. doi: 10.1111/ecc.12817.
• Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).
  Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, Berardi R, Capasso G, Caprio M, Ceccato F, Corona G, Della Casa S, De Nicola L, Faustini-Fustini M, Fiaccadori E, Gesualdo L, Gori S, Lania A, Mantovani G, Menè P, Parenti G, Pinto C, Pivonello R, Razzore P, Regolisti G, Scaroni C, Trepiccione F, Lenzi A, Peri A; the: Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology; Italian Society of Nephrology; and Italian Association of Medical Oncology.
  J Endocrinol Invest. 2018 Jan;41(1):3-19. doi: 10.1007/s40618-017-0776-x. Epub 2017 Nov 20
• 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.
  Cavaliere D, Cirocchi R, Coccolini F, Fagotti A, Fambrini M, Federici O, Lorusso D, Vaira M, Ceresoli M, Delrio P, Garofalo A, Pignata S, Scollo P, Trojano V, Amadori A, Ansaloni L, Cariti G, De Cian F, De Iaco P, De Simone M, Deraco M, Donini A, Fiorentini G, Frigerio L, Greggi S, Macrì A, Pasqual EM, Roviello F, Sammartino P, Sassaroli C, Scambia G, Staudacher C, Vici P, Vizza E, Valle M; Italian Society of Surgical Oncology (SICO); Italian Society of Obstetrics and Gynaecology (SIGO); Italian Association of Hospital Obstetricians and Gynaecologists (AOGOI); Italian Association of Medical Oncology (AIOM).
  Tumori. 2017 Nov 23;103(6):525-536. doi: 10.5301/tj.5000623. Epub 2017 Apr 20
• Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).
  Pedrazzoli P, Silvestris N, Santoro A, Secondino S, Brunetti O, Longo V, Mancini E, Mariucci S, Rampino T, Delfanti S, Brugnatelli S, Cinieri S.
  ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017.
• External quality assessment for EGFR mutations in Italy: improvements in performances over the time.
  Normanno N, Fenizia F, Castiglione F, Barberis M, Taddei GL, Truini M, De Rosa G, Pinto C, Marchetti A.
  ESMO Open. 2017 May 26;2(2):e000160. doi: 10.1136/esmoopen-2017-000160. eCollection 2017
• Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy.
  Puglisi F, Agostinetto E, Gerratana L, Bozza C, Cancian M, Iannelli E, Ratti G, Cinieri S, Numico G.
  Future Oncol. 2017 Feb;13(3):233-248. doi: 10.2217/fon-2016-0383. Epub 2016 Sep 12
• Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.
  Lambertini M, Cinquini M, Moschetti I, Peccatori FA, Anserini P, Valenzano Menada M, Tomirotti M, Del Mastro L.
  Eur J Cancer. 2017 Jan;71:25-33. doi: 10.1016/j.ejca.2016.10.034. Epub 2016 Dec 9
• Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care).
  Zagonel V, Franciosi V, Brunello A, Biasco G, Broglia C, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Marchetti P, Massa E, Mastromauro C, Melotti B, Meriggi F, Nacci A, Pavese I, Piva E, Quirino M, Roselli M, Sacco C, Tonini G, Trentin L, Ucci G, Labianca R, Gori S, Pinto C, Cascinu S; AIOM Simultaneous and Continuous Care (SCC), Task Force: ESMO Italian DCs.
  Tumori. 2017 Jan 21;103(1):9-14. doi: 10.5301/tj.5000593. Epub 2016 Dec 19.
• Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement.
  Gori S, Pinto C, Caminiti C, Aprile G, Marchetti P, Perrone F, Di Maio M, Omodeo Salè E, Mancuso A, De Cicco M, Di Costanzo F, Crispino S, Passalacqua R, Merlano M, Zagonel V, Fioretto L, Micallo G, Labianca R, Bordonaro R, Comandone A, Spinsanti S, Iacono C, Nicolis F; AIOM (Italian Medical Oncology Association) and AIOM Foundation.
  Tumori. 2016 Dec 1;102(6):e25-e27. doi: 10.5301/tj.5000582
• Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).
  Di Maio M, Bruzzi P, Perrone F, Torri V, Montemurro F, Tiseo M, Vasile E.
  ESMO Open. 2016 Dec 12;1(6):e000109. doi: 10.1136/esmoopen-2016-000109. eCollection 2016
• Epidemiology of cancer in Italy: from real data to the need for cancer networks.
  Pinto C, Mangone L.
  Recenti Prog Med. 2016 Oct;107(10):505-506. doi: 10.1701/2454.25696.
• Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey.
  Caccialanza R, Cereda E, Pinto C, Cotogni P, Farina G, Gavazzi C, Gandini C, Nardi M, Zagonel V, Pedrazzoli P.
  Nutrition. 2016 Sep;32(9):1028-32. doi: 10.1016/j.nut.2016.02.005. Epub 2016 Mar 2.
• Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey.
  Zagonel V, Torta R, Franciosi V, Brunello A, Biasco G, Cattaneo D, Cavanna L, Corsi D, Farina G, Fioretto L, Gamucci T, Lanzetta G, Magarotto R, Maltoni M, Mastromauro C, Melotti B, Meriggi F, Pavese I, Piva E, Sacco C, Tonini G, Trentin L, Ermacora P, Varetto A, Merlin F, Gori S, Cascinu S, Pinto C; AIOM Simultaneous & Continuous Care (SCC) Task Force-ESMO-DCs.
  J Cancer. 2016 Sep 27;7(14):1968-1978. eCollection 2016
• Non-clinical factors influencing pain intensity in cancer patients: Socio-cultural-economic status, awareness of disease and the relation with the oncologist.
  Corli O, Martoni AA, Porcu L, Roberto A, Pinto C, Torri V, Guglieri I, Zagonel V; EPIDEMIOLOGY STUDY OF PAIN IN ONCOLOGY (ESOPO) GROUP.
  Eur J Intern Med. 2016 Sep;33:e18-9. doi: 10.1016/j.ejim.2016.04.019. Epub 2016 May 5
• What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities.
  Moretti A, Ghidini M, De Angelis C, Lambertini M, Cremolini C, Imbimbo M, Berardi R, Di Maio M, Cascinu S, La Verde N.
  PLoS One. 2016 Jul 12;11(7):e0159146. doi: 10.1371/journal.pone.0159146. eCollection 2016
• Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.
  Alterio D, Franco P, Numico G, Licitra L, Cossu Rocca M, Ferrari A, Pinto C, Russi EG, Ricardi U, Jereczek Fossa BA.
  Med Oncol. 2016 Jul;33(7):76. doi: 10.1007/s12032-016-0781-5. Epub 2016 Jun 11
• AIOM chooses ESMO Open-Cancer Horizons as its official journal: a warm welcome from ESMO Open.
  Zielinski CC, Pinto C.
  ESMO Open. 2016 Jul 1;1(4):e000080. eCollection 2016
• Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE).
  Caccialanza R, Pedrazzoli P, Cereda E, Gavazzi C, Pinto C, Paccagnella A, Beretta GD, Nardi M, Laviano A, Zagonel V.
  J Cancer. 2016 Jan 1;7(2):131-5. doi: 10.7150/jca.13818. eCollection 2016.
• Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
  Barni S, Maiello E, Di Maio M, Ardizzoni A, Cappuzzo F, Maranzano E, Novello S, Bennati C, Ori A, Rizzoli S, Crinò L; RIGHT-3 study group.
  Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19
• The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.
  Normanno N, Pinto C, Castiglione F, Fenizia F, Barberis M, Marchetti A, Fontanini G, De Rosa G, Taddei GL.
  J Transl Med. 2015 Sep 3;13:287. doi: 10.1186/s12967-015-0655-1.
• Clinical and organizational issues in the management of surviving breast and colorectal cancer patients: attitudes and feelings of medical oncologists.
  Numico G, Pinto C, Gori S, Ucci G, Di Maio M, Cancian M, De Lorenzo F, Silvestris N.
  PLoS One. 2014 Jul 1;9(7):e101170. doi: 10.1371/journal.pone.0101170. eCollection 2014
• Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).
  Pedrazzoli P, Baldanti F, Donatelli I, Castrucci MR, Puglisi F, Silvestris N, Cinieri S; Italian Society of Medical Oncology.
  Ann Oncol. 2014 Jun;25(6):1243-7. doi: 10.1093/annonc/mdu114. Epub 2014 Mar 11.
• A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.
  Barni S, Lorusso V, Giordano M, Sogno G, Gamucci T, Santoro A, Passalacqua R, Iaffaioli V, Zilembo N, Mencoboni M, Roselli M, Pappagallo G, Pronzato P.
  Med Oncol. 2014 Jan;31(1):797. doi: 10.1007/s12032-013-0797-z. Epub 2013 Dec 5
• Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancer.
  Normanno N, Pinto C, Taddei G, Gambacorta M, Castiglione F, Barberis M, Clemente C, Marchetti A.
  J Thorac Oncol. 2013 Jun;8(6):773-8. doi: 10.1097/JTO.0b013e31828c2b08.
• Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.
  Cortinovis D, Beretta G, Piazza E, Luchena G, Aglione S, Bertolini A, Buzzoni R, Cabiddu M, Carnaghi C, Danova M, Farina G, Ferrari V, Frascaroli M, Reni M, Tansini G; AIOM Lombardia.
  Tumori. 2013 Jan-Feb;99(1):45-50. doi: 10.1700/1248.13787
• Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
  Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Barbato E, Beretta GD, Bravi S, Caffo O, Canobbio L, Carrozza F, Cinieri S, Cruciani G, Dinota A, Gebbia V, Giustini L, Graiff C, Molino A, Muggiano A, Pandoli G, Puglisi F, Tagliaferri P, Tomao S, Lunardi G, Venturini M; AIOM Working Group “Interaction with Regional Sections” (2009-2011).
  Tumori. 2013 Jan-Feb;99(1):35-8. doi: 10.1700/1248.13785.
• A new informed consent form model for cancer patients: preliminary results of a prospective study by the Italian Association of Medical Oncology (AIOM).
  Gori S, Greco MT, Catania C, Colombo C, Apolone G, Zagonel V; AIOM Group for the Informed Consent in Medical Oncology.
  Patient Educ Couns. 2012 May;87(2):243-9. doi: 10.1016/j.pec.2011.08.008. Epub 2011 Sep 16
• KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.
  Normanno N, Pinto C, Castiglione F, Bardelli A, Gambacorta M, Botti G, Nappi O, Siena S, Ciardiello F, Taddei G, Marchetti A.
  PLoS One. 2011;6(12):e29146. doi: 10.1371/journal.pone.0029146. Epub 2011 Dec 21
• Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM).
  Barni S, Venturini M, Molino A, Donadio M, Rizzoli S, Maiello E, Gori S.
  Tumori. 2011 Sep-Oct;97(5):559-63. doi: 10.1700/989.10711.
• Disparity in the “time to patient access” to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
  Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Barbato E, Beretta GD, Bravi S, Caffo O, Canobbio L, Carrozza F, Cinieri S, Cruciani G, Dinota A, Gebbia V, Giustini L, Graiff C, Molino A, Muggiano A, Pandoli G, Puglisi F, Tagliaferri P, Tomao S, Venturini M; AIOM Working Group “Interactions with Regional Sections” (2009-2011).
  Tumori. 2011 Jul-Aug;97(4):442-8. doi: 10.1700/950.10395
• Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM).
  Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Beretta GD, Caffo O, Caroti C, Crinò L, De Laurentiis M, Dinota A, Di Vito F, Gebbia V, Giustini L, Graiff C, Guida M, Lelli G, Lombardo M, Muggiano A, Puglisi F, Romito S, Salvagno L, Tagliaferri P, Terzoli E, Venturini M; AIOM Working Group Interaction with Regional Sections (2007-2009).
  Tumori. 2010 Nov-Dec;96(6):1010-5
• Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey.
  Roila F, Ballatori E, Labianca R, De Braud F, Borgonovo K, Martelli O, Gallo C, Tinazzi A, Perrone F; Italian Medical Oncology Association (AIOM).
  Tumori. 2009 Nov-Dec;95(6):647-51
• Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey.
  Catania C, Zagonel V, Fosser V, La Verde N, Bertetto O, Iacono C, Venturini M, Radice D, Adamoli L, Boccardo F.
  Ann Oncol. 2008 Nov;19(11):1947-54. doi: 10.1093/annonc/mdn381. Epub 2008 Jun 12
• Agreement between oncology guidelines and clinical practice in Italy: the ‘right’ program. A project of the Italian Association of Medical Oncology (AIOM).
  Barni S, Venturini M, Beretta GD, Gori S, Molino A, Carnaghi C, Labianca R, Sgarbi S, Simoni L, Maiello E; AIOM Guidelines Task Force.
  Ann Oncol. 2007 Jun;18 Suppl 6:vi179-84
• Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).
  Mandalà M, Falanga A, Piccioli A, Prandoni P, Pogliani EM, Labianca R, Barni S; working group AIOM.
  Crit Rev Oncol Hematol. 2006 Sep;59(3):194-204. Epub 2006 Jul 11
• The AIOM (Italian Association of Medical Oncology) practice guidelines for breast neoplasms.
  Del Mastro L; Associazione Italiana di Oncologia Medica; Istituto per la Ricerca sul Cancro.
  Tumori. 2004 Mar-Apr;90(2):1-8

Tumori Journal and Esmo Open: Cancer Horizons are the AIOM official journals.